People's Justice

Case trackerActive

Oxbryta use and a claim for harm Updates

Updated Oct 6, 2026

Took Oxbryta for sickle cell disease? Ask your care team about treatment.

Register interest

From the record

Latest updates

  1. DATE

    WHAT HAPPENED

    Pfizer withdraws Oxbryta worldwide

    SOURCE

    pfizer.com

  2. DATE

    WHAT HAPPENED

    FDA expands Oxbryta to children as young as four

    SOURCE

    fda.gov

  3. DATE

    WHAT HAPPENED

    FDA grants accelerated approval to Oxbryta

    SOURCE

    fda.gov

Case timeline

From court orders and filings. Dates marked scheduled can move.

  1. November 2019

    FDA grants accelerated approval to Oxbryta fda.gov

  2. December 2021

    FDA expands Oxbryta to children as young as four fda.gov

  3. September 2024

    Pfizer withdraws Oxbryta worldwide pfizer.com

Stay informed

Get free updates about Oxbryta use and a claim for harm

No phone call required. We will email you about relevant court filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. FDA Oxbryta withdrawal safety alert, September 26, 2024FDA Oxbryta withdrawal safety alert, September 26, 2024 · regulator
  2. Pfizer worldwide Oxbryta withdrawal announcement, September 25, 2024Pfizer worldwide Oxbryta withdrawal announcement, September 25, 2024
  3. EMA Oxbryta final-review overview and dated procedure recordEMA Oxbryta final-review overview and dated procedure record
  4. Vichinsky et al., original HOPE randomized trial, 2019Vichinsky et al., original HOPE randomized trial, 2019 · study
  5. Howard et al., HOPE 72-week follow-up, 2021Howard et al., HOPE 72-week follow-up, 2021 · study
  6. MedlinePlus voxelotor drug information and withdrawal noticeMedlinePlus voxelotor drug information and withdrawal notice · regulator
  7. Cosey v. Global Blood Therapeutics and Pfizer, Doc. 33, July 27, 2026Cosey v. Global Blood Therapeutics and Pfizer, Doc. 33, July 27, 2026 · court
  8. ABA Model Rule 1.5 feesABA Model Rule 1.5 fees
  9. HHS medicalrecords accessHHS medicalrecords access · regulator
  10. SDNY filing-time FAQSDNY filing-time FAQ · court
  11. U.S. Courts civil cases processU.S. Courts civil cases process · court

Want the complete picture?

Read the case guide for eligibility, evidence and your next steps.

View the full Oxbryta use and a claim for harm case guide →